We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Biomarker POC Test Could Identify Patients at Risk of Severe Dengue

By LabMedica International staff writers
Posted on 26 Dec 2023
Print article
Image: Researchers have taken a step forward in diagnosing severe cases of dengue (Photo courtesy of NTU Singapore)
Image: Researchers have taken a step forward in diagnosing severe cases of dengue (Photo courtesy of NTU Singapore)

Dengue is typically a mild illness, yet approximately 15% of cases can progress to critical dengue, demanding intensive care and monitoring. Current early detection methods for severe dengue, such as PCR and ELISA tests conducted on blood samples, often fall short in sensitivity. Additionally, the World Health Organization's recommended symptom-based guidelines, which include fever, headache, eye pain, rash, and minor bleeding, have limited accuracy (6 to 18%) in detecting severe dengue due to symptom overlap with milder forms and other illnesses.

Scientists and clinicians at NTU Singapore (Singapore) have now identified two biomarkers — sST2 and suPAR — present in the blood of dengue patients that show promise in identifying those at risk of developing severe dengue during the disease's initial stages. This discovery emerged from a study between 2016 and 2019 involving 129 individuals treated for dengue. Given that lateral flow tests for sST2 and suPAR, proteins associated with heart health and disease, are commercially available for heart failure assessment, the team is exploring the possibility of combining these into a single test kit tailored for severe dengue detection.

Elevated levels of sST2 indicate cardiac stress and fibrosis, useful for gauging the severity of heart failure, while high suPAR levels are indicative of heightened inflammation and an increased risk of cardiac complications. By tracking these markers, researchers gain insights into cardiac conditions and disease progression. The team believes this novel approach could significantly improve accuracy in predicting severe dengue cases, with an estimated 55 to 60% accuracy rate, outperforming existing WHO guidelines. The development of these test kits could help healthcare professionals differentiate between mild dengue cases and severe ones requiring hospital admission.

Related Links:
NTU Singapore

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.